euro adhoc: quarterly or semiannual financial statement / curasan: First quarterly break-even result
Further inquiry note: Dr. Erwin Amashaufer, curasan AG, Tel. +49 6027/46 86-465, email: ir@curasan.de Branche: Biotechnology ISIN: DE0005494538 WKN: 549453 Index: CDAX, Classic All Share, Prime All Share Börsen: Börse Frankfurt / regulated dealing/prime standard Börse Berlin / free trade Börse Hamburg / free ...